Company Data
Inhibikase Therapeutics Inc.
Ticker
IKT
Current Price
$2.11 4.98%
Market Cap
$278.6M
Price Target
Refer to Report
Volume
1.7M
52wk Range
$1.33 - $2.36
Overview
Inhibikase Therapeutics (Nasdaq: IKT) is a clinical-stage pharmaceutical company focused on developing and commercializing small-molecule kinase inhibitor therapeutics that modify Parkinson’s disease and drive functional reversal inside and outside of the brain. Inhibikase is headquartered in Atlanta, Georgia with additional offices in Boston, Massachusetts.